Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erector Spinae Block Versus PECS Block Type II for Breast Surgeries: a Randomized Controlled Trial

NCT04284124 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT04284124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04284124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erector Spinae Block Versus PECS Block Type II for Breast Surgeries: a Randomized Controlled Trial
Lead sponsor
National Cancer Institute, Egypt
Phase
Not applicable
Overall status
Completed
Start date
March 19, 2020
Completion date
March 10, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia